Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Romain Fournier

Chief Editor
Having worked in the British, French and Swiss financial press, Romain is able to report on local and international issues, as comfortable in French as in the language of Shakespeare, Romain Fournier leads the editorial team at Marketscreener. Fine connoisseur of the English-speaking markets, Romain delivers an editorial every day on US and UK markets.

Global markets live: Tesla, Experian, Roche, Activision, Amazon...

11/17/2021 | 12:21pm EST

Every morning, the MarketScreener team compiles and summarizes the most important news related to listed companies around the world.

 

 

  • Elon Musk is pursuing the disposal of Tesla shares for tax reasons.
  • SSE Plc is considering selling a minority stake in its networks.
  • Tony Staffieri takes over Rogers Communications.
  • Experian raises its forecast.
  • Volkswagen to change head in China.
  • Roche ends partnership with Atea Pharmaceuticals.
  • Activision's CEO knew about sexual harassment at the company for years, according to the Wall Street Journal.
  • Lonza is expanding microbial development laboratory capabilities at its Swiss site.
  • Miramax sues Quentin Tarantino over the director's NFT plans for Pulp Fiction.
  • China Duty Free Group gets green light for $5 billion IPO in Hong Kong.
  • Target on Wednesday raised its full-year like-for-like revenue forecast after beating expectations in the third quarter on anticipation of holiday shopping by U.S. households. However, the stock is down 3.1% in pre-market trading as margins in the quarter were affected by supply chain strains.
  • Amazon announced Wednesday that it will stop accepting Visa credit cards issued in the U.K. starting next year due to high fees charged on transactions by the U.S. payment card giant. Visa shares are down 2.5% in pre-market trading.
  • Pfizer said Tuesday it has applied for U.S. approval of its experimental COVID-19 antiviral treatment after a clinical trial showed it reduced the risk of hospitalization or death by 89 percent in people at risk of developing severe forms of the disease. The stock gained 0.8% in trading before the Wall Street opening. The group also announced the retirement of its chief financial officer, Frank D'Amelio.
  • Biogen announced Wednesday that the European Medicines Agency panel voted against the marketing application for its Alzheimer's disease treatment. The U.S. laboratory is down 3.6% in pre-market trading.
  • Lowe’s raised its full-year sales forecast on Wednesday on the back of strong construction demand and a robust U.S. housing market. The stock is up 3.4% in pre-market trading.
  • Lucid Group - The electric vehicle maker is up 8.6 percent to $60.3 a share in premarket trading after announcing Tuesday that reservations for its cars reached 13,000 units in the third quarter. 
  • Vir Biotechnology - The U.S. has signed two contracts worth about $1 billion (nearly 900 million euros) for an order for the COVID-19 monoclonal antibody treatment sotrovimab, developed by British drugmaker GSK and U.S. biotech Vir, the two companies announced Wednesday in a joint statement. Vir's shares rose 8.9 percent to $36.40 in premarket trading.
  • Baidu on Wednesday reported better-than-expected third-quarter revenue and adjusted earnings thanks to higher advertising revenue and demand for its cloud computing and artificial intelligence products. The stock is up 1.6% in pre-market trading.


Major earnings releases: Nvidia, Cisco, Lowe's, Target, Baidu, Experian, NIBE Industrier, Grifols, Embracer, Royal Unibrew...


ę Axiona 2021
Stocks mentioned in the article
ChangeLast1st jan.
ACTIVISION BLIZZARD, INC. -1.70% 79.97 Delayed Quote.20.20%
ALPHA MOS -9.38% 2.61 Real-time Quote.11.06%
ARCHOSAUR GAMES INC. -6.53% 8.59 End-of-day quote.6.84%
EMBRACER GROUP AB (PUBL) -7.86% 83.88 Delayed Quote.-13.09%
EXPERIAN PLC -3.27% 2960 Delayed Quote.-18.81%
GENSIGHT BIOLOGICS S.A. -3.98% 4.1 Real-time Quote.-26.26%
LONZA GROUP AG -4.67% 612.4 Delayed Quote.-19.59%
NIBE INDUSTRIER AB (PUBL) -5.76% 85.76 Delayed Quote.-37.29%
NVIDIA CORPORATION -0.01% 233.72 Delayed Quote.-20.53%
ROCHE HOLDING AG -4.41% 344.75 Delayed Quote.-9.06%
ROGERS COMMUNICATIONS INC. -0.67% 60.73 Delayed Quote.1.51%
ROYAL UNIBREW A/S -2.50% 772.4 Delayed Quote.4.77%
SSE PLC -1.44% 1537.5 Delayed Quote.-6.76%
TESLA, INC. -1.47% 930 Delayed Quote.-12.00%
VOLKSWAGEN AG -5.92% 176.52 Delayed Quote.-0.54%